DR. ALLAN M. GREEN, MD, PHD
Osteopathic Medicine at Mount Auburn St, Cambridge, MA
License number
Massachusetts 37723
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
124 Mount Auburn St SUITE 200N, Cambridge, MA 02138
Phone
(617) 447-5999
Personal information
See more information about ALLAN M. GREEN at radaris.comName
Address
Phone
4 Belmont Dr, Chelmsford, MA 01824
3 Steven Cir, Natick, MA 01760
76 Shadow Brook Est, South Hadley, MA 01075
75 Cambridge Pkwy UNIT E603, Cambridge, MA 02142
19 Francis Ave, Cambridge, MA 02138
Organization information
See more information about ALLAN M. GREEN at bizstanding.comAllan M. Green
19 Francis Ave, Cambridge, MA 02138
Phone:
(617) 576-9132 (Phone)
Email:
SIC:
1531 - Operative Builders
Allan M Green, LLC
124 Mt Auburn St, Cambridge, MA 02138
Industry:
New Diagnostics Development
Medical Doctors:
Allan Green (Medical Doctor),James Allan Karlson (Medical Doctor)
Professional information
Allan Green
Location:
Cambridge, Massachusetts
Industry:
Law Practice
Skills:
Intellectual Property, Licensing, Biotechnology, Venture Capital, Patents, Technology Transfer, Lifesciences, Due Diligence, Pharmaceutical Industry, Mergers, Medical Devices, Start-ups, Patent Prosecution, Corporate Governance, Private Equity, Strategic Planning, Joint Ventures, Drug Discovery, Trademarks, Corporate Law, Regulatory Affairs, Clinical Research, Medical Imaging, Mergers & Acquisitions
Methods And Compositions To Treat Glycosaminoglycan-Associated Molecular Interactions
US Patent:
2006011, Jun 1, 2006
Filed:
Jun 6, 2005
Appl. No.:
11/147150
Inventors:
Robert Kisilevsky - Kingston, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
International Classification:
A61K 31/737
US Classification:
514054000
Abstract:
Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described.
Methods And Compositions To Treat Glycosaminoglycan-Associated Molecular Interactions
US Patent:
2007007, Apr 5, 2007
Filed:
Sep 19, 2006
Appl. No.:
11/523811
Inventors:
Robert Kisilevsky - Kington, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
Assignee:
Neurochem (International) Limited - Lausanne
Queen's University at Kingston - Kington
Queen's University at Kingston - Kington
International Classification:
A61K 38/16
US Classification:
514008000
Abstract:
Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described
Methods For Using Annexin For Detecting Cell Death In Vivo And Treating Associated Conditions
US Patent:
6843980, Jan 18, 2005
Filed:
Apr 3, 2002
Appl. No.:
10/114927
Inventors:
Allan M. Green - Cambridge MA, US
Assignee:
Theseus Imaging, Corp. - Boston MA
International Classification:
A61B 1000, A61B 500, A61B 800
US Classification:
424 96, 424 111, 424 165, 424 91
Abstract:
The present invention provides methods and compositions for imaging cell death in vivo, as well as methods and compositions for tumor radiotherapy.
Methods And Compositions For Predicting The Response To A Therapeutic Regimen In A Subject Having A Disease Associated With Cell Death
US Patent:
2005001, Jan 20, 2005
Filed:
Apr 6, 2004
Appl. No.:
10/819890
Inventors:
Allan Green - Cambridge MA, US
Neil Steinmetz - Atlantis FL, US
Neil Steinmetz - Atlantis FL, US
Assignee:
Theseus Imaging Corporation - Boston MA
International Classification:
A61K049/00, A61K039/395, A61K033/24
US Classification:
424009600, 424144100, 424145100, 424649000
Abstract:
The present invention provides methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death.
Pharmaceutical Compositions Containing Chondroitinase And Uses Therefor
US Patent:
6200564, Mar 13, 2001
Filed:
Apr 10, 1998
Appl. No.:
9/058684
Inventors:
J. Thomas Lamont - Newton MA
K. Ramakrishnan Bhaskar - Lexington MA
Allan M. Green - Cambridge MA
K. Ramakrishnan Bhaskar - Lexington MA
Allan M. Green - Cambridge MA
International Classification:
A61K 3847
US Classification:
424 9461
Abstract:
Gastrointestinal mucus from patients suffering from cystic fibrosis has been found to contain large amounts of chondroitin sulfate polymer. This finding indicates that the enzyme chondroitinase is useful for preventing gastrointestinal mucus from accumulating in cystic fibrosis patients, and subjects suffering from other diseases or conditions characterized by excess mucus secretion.
Methods And Compositions To Treat Glycosaminoglycan-Associated Molecular Interactions
US Patent:
2002019, Dec 19, 2002
Filed:
Oct 2, 2001
Appl. No.:
09/970148
Inventors:
Robert Kisilevsky - Kingston, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
Allan Green - Cambridge MA, US
Francine Gervais - Ile Bizard, CA
Assignee:
Queen's University
International Classification:
A61K031/44, A01N043/42
US Classification:
514/292000
Abstract:
Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described.
Methods Of Using Labelled Verotoxin B Subunit
US Patent:
2003010, Jun 5, 2003
Filed:
May 15, 2002
Appl. No.:
10/147338
Inventors:
Allan Green - Cambridge MA, US
International Classification:
A61K051/00
US Classification:
424/001410
Abstract:
The invention pertains to methods for labeling antigen presenting cells, by contacting the antigen presenting cells with a labeled verotoxin. The invention also pertains to methods for determining the ability of an antigen presenting cell to stimulate an immune response.
Verotoxin B Subunit For Immunization
US Patent:
8367071, Feb 5, 2013
Filed:
Feb 13, 2003
Appl. No.:
10/368314
Inventors:
Allan M. Green - Cambridge MA, US
Assignee:
Inserm-Transfert - Paris
Universite Pierre et Marie Curie (UPMC) - Paris Cedex
Universite Pierre et Marie Curie (UPMC) - Paris Cedex
International Classification:
A61K 39/395
US Classification:
4241931, 4241851
Abstract:
Methods for stimulating an immune response in a mammal by administering a toxin-antigen conjugate are provided. Pharmaceutical compositions and methods for treating an antigen-related state are also described.
Verotoxin B Subunit For Immunization
US Patent:
2002008, Jun 27, 2002
Filed:
May 14, 1999
Appl. No.:
09/312338
Inventors:
ALLAN M. GREEN - CAMBRIDGE MA, US
International Classification:
A61K039/00, A61K039/38, A61K039/02, A61K039/108
US Classification:
424/184100, 424/236100, 424/241100
Abstract:
Methods for stimulating an immune response in a mammal by administering a toxin-antigen conjugate are provided. Pharmaceutical compositions and methods for treating an antigen-related state are also described.